Events after the end of the reporting period

On 15 July 2016, we subscribed to the first listing of shares on Alternext Paris of the French biotech Pharnext for amount of €2.75 million.

On 26 July 2016, Galapagos’ Special Shareholders’ Meeting appointed Dr. Mary Kerr as independent director for a period ending immediately after the Annual Shareholders’ Meeting of 2020.